Sutro Biopharma STRO
NASDAQ STRO
$10.79 -0.75 (-6.50%)
At close: Oct 21, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Price to FCF (2018 - 2019)

Updated

Sutro Biopharma's (STRO) Price to FCF came in at 65.72 for Q2 2019, up 53.0% from the prior quarter.

Analysis

Sutro Biopharma (STRO) Price to FCF (2018 - 2019) Analysis & Trends

For FY2018, Sutro Biopharma's Price to FCF stood at 4.67.

  • According to Business Quant data, Price to FCF for the three prior quarters was 42.95 (Q1 2019), 4.67 (Q4 2018) and 0.58 (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Sutro Biopharma 179.64 Mn -498.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 65.72
Mar 31, 2019 42.95
Dec 31, 2018 4.67
Sep 30, 2018 0.58
API Access

Sutro Biopharma Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=STRO&period=max&api_key=YOUR_API_KEY